United States · Venture startup

Who invested in ProstaGene

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$400Kraised across 1 round since 2015, from 1 source

Latest round
Venture, $400KMar 2015
Investors
0
See who backed them

The rounds

  1. Mar 2015
    Venture$400K

    No investor was named in the report.

    From a historical funding recordSEC filing: $400K sold, first sale Feb 2015

Funding filed with regulators

ProstaGene filed 2 raises, $1.2M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Apr 2016$400K4 investorsequityof $1.4M offeredSEC Form D
  2. Feb 2015$825K6 investorsequityof $1.0M offeredSEC Form D

Founders and team

From the SEC filings it signed: 2 on the team.

  • Dan MatthiasExecutive Officer, Directori
  • Richard PestellExecutive Officer, Directori

Quick answers about ProstaGene

How much has ProstaGene raised?

ProstaGene has raised $400K across 1 round since 2015.

When did ProstaGene last raise?

ProstaGene's most recent round was a Venture of $400K in Mar 2015.

What was ProstaGene's biggest round?

Its most recent round, $400K in Mar 2015, is also its largest on record.

What stage is ProstaGene at?

ProstaGene's latest named round is a Venture, in Mar 2015.

Where is ProstaGene based?

ProstaGene is based in the United States.

Companies like ProstaGene

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.